SEC Filing | T2 Biosystems Inc.

View:

SEC FORM 3 SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Jones Adrian M

(Last)

(First)

(Middle)

C/O GOLDMAN, SACHS & CO.

200 WEST STREET

(Street)

NEW YORK

10282

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
03/09/2016

3. Issuer Name and Ticker or Trading Symbol
T2 Biosystems, Inc. [ TTOO ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	4,157,240⁽²⁾	I	See footnotes⁽¹⁾⁽²⁾

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)

Explanation of Responses:

1. The Reporting Person is a managing director of Goldman, Sachs & Co. ("Goldman Sachs"). Goldman Sachs is a wholly owned subsidiary of The Goldman Sachs Group, Inc. ("GS Group"). The Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein, if any.

2. GS Group and Goldman Sachs may be deemed to beneficially own indirectly, in the aggregate, 4,157,240 shares of Common Stock, par value $0.001 per share (the "Common Stock") of T2 Biosystems, Inc. by reason of the direct beneficial ownership of Common Stock by certain investment entities (the "GS Funds") because GS Group, or affiliates of GS Group and Goldman Sachs, are the general partner, managing general partner, managing partner, managing member or member of each of the GS Funds. Goldman Sachs is the investment manager of certain of the GS Funds.

Remarks:

	/s/ Yvette Kosic, Attorney-in-fact	03/11/2016
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

                 POWER OF ATTORNEY

      The undersigned does hereby appoint Bruce A. Albert, Anthony DeRose,
Andrea DeMar, Yvette Kosic, Rachel Parrish, Justine Hansen and Kevin P.
Treanor, (and any other employee of The Goldman Sachs Group, Inc. or one of
its affiliates designated in writing by one of the attorneys-in-fact), his
true and lawful attorneys, and each one of them his true and lawful attorney,
with power to act without the other, and with full power of substitution and
resubstitution, to execute for his and in his name any Initial Statement of
Beneficial Ownership of Securities on Form 3, any Statement of Changes in
Beneficial Ownership on Form 4 and any Annual Statement of Changes in
Beneficial Ownership on Form 5, or any similar or successor form, which may be
required to be filed by him with the Securities and Exchange Commission and
any and all instruments necessary or incidental therewith, hereby granting
unto said attorneys and each of them full power and authority to do and
perform in the name and on behalf of the undersigned, and in any and all
capacities, every act and thing whatsoever required or necessary to be done
in and about the premises, as fully and to all intents and purposes as the
undersigned might or could do in person, hereby ratifying and approving the
act of said attorneys and each of them.

      This power of attorney shall not be affected by the subsequent
disability or incompetence of the principal. This power of attorney shall
remain in full force and effect until either revoked in writing by the
undersigned or until such time as the person or persons to whom power of
attorney has been hereby granted cease(s) to be an employee of The Goldman
Sachs Group, Inc. or one of its affiliates.

      In witness thereof the undersigned hereunto signed his name this 30th
day of September, 2009.

/s/ Adrian M. Jones
-----------------------------
Adrian M. Jones